UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

Journal of clinical oncology, 2023-03, Vol.41 (7), p.1453-1465

2023

Volltextzugriff (PDF)

Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma

Cancer Immunology, Immunotherapy, 2016-11, Vol.65 (11), p.1339-1352

2016

Volltextzugriff (PDF)

Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study

PloS one, 2014-07, Vol.9 (7), p.e102231-e102231

2014

Volltextzugriff (PDF)

Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma

Clinical cancer research, 2024-02, Vol.30 (4), p.865-876

2024

Volltextzugriff (PDF)

Bevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma

Journal of neuro-oncology, 2024, Vol.166 (1), p.89-98

2024

Volltextzugriff (PDF)

Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models

PloS one, 2012-01, Vol.7 (1), p.e30815

2012

Volltextzugriff (PDF)

The Presence of Survivin on B Cells from Myasthenia Gravis Patients and the Potential of an Antibody to a Modified Survivin Peptide to Alleviate Weakness in an Animal Model

The Journal of immunology (1950), 2020-10, Vol.205 (7), p.1743-1751

2020

Volltextzugriff (PDF)

Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth In Vivo

Clinical cancer research, 2018-06, Vol.24 (11), p.2642-2652

2018

Volltextzugriff (PDF)

Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination

Oncotarget, 2017-12, Vol.8 (70), p.114722-114735

2017

Volltextzugriff (PDF)

Black Bone Disease of the Skull

World neurosurgery, 2020-02, Vol.134, p.548-548

2020

Volltextzugriff (PDF)

Disparities among racial/ethnic groups of patients diagnosed with ependymoma: analyses from the Surveillance, Epidemiology and End Results (SEER) registry

Journal of neuro-oncology, 2019-08, Vol.144 (1), p.43-51

2019

Volltextzugriff (PDF)

Lateral Temporal Approach for Image-Guided Stereotactic Biopsy of Pineal Region Tumors

World neurosurgery, 2021-03, Vol.147, p.144-149

2021

Volltextzugriff (PDF)

Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade glioma

Scientific reports, 2024-08, Vol.14 (1), p.19474-16, Article 19474

2024

Volltextzugriff (PDF)

Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma

Expert review of vaccines, 2014-03, Vol.13 (3), p.377-385

2014

Volltextzugriff (PDF)

Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells

Cancer research (Chicago, Ill.), 2006-07, Vol.66 (14), p.7270-7275

2006

Volltextzugriff (PDF)

Life-Threatening Mannitol-Induced Hyperkalemia in Neurosurgical Patients

World neurosurgery, 2016-07, Vol.91, p.672.e5-672.e9

2016

Volltextzugriff (PDF)

Site-Specific Conjugation of Boron-Containing Dendrimers to Anti-EGF Receptor Monoclonal Antibody Cetuximab (IMC-C225) and Its Evaluation as a Potential Delivery Agent for Neutron Capture Therapy

Bioconjugate chemistry, 2004-01, Vol.15 (1), p.185-194

2004

Volltextzugriff (PDF)

Meta-analysis of overall survival and postoperative neurologic deficits after resection or biopsy of butterfly glioblastoma

Neurosurgical review, 2022-12, Vol.45 (6), p.3511-3521

2022

Volltextzugriff (PDF)

KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma

Journal of neuro-oncology, 2018-12, Vol.140 (3), p.519-527

2018

Volltextzugriff (PDF)

Novel vaccines for glioblastoma: clinical update and perspective

Immunotherapy, 2016-11, Vol.8 (11), p.1293-1308

2016

Volltextzugriff (PDF)

Molecular Targeting and Treatment of Composite EGFR and EGFRvIII-Positive Gliomas Using Boronated Monoclonal Antibodies

Clinical cancer research, 2008-02, Vol.14 (3), p.883-891

2008

Volltextzugriff (PDF)

Molecular Targeting and Treatment of an Epidermal Growth Factor Receptor–Positive Glioma Using Boronated Cetuximab

Clinical cancer research, 2007-02, Vol.13 (4), p.1260-1268

2007

Volltextzugriff (PDF)

Radiologic response to radiation therapy concurrent with temozolomide for progressive simple dysembryoplastic neuroepithelial tumor

Acta neurochirurgica, 2016-07, Vol.158 (7), p.1363-1366

2016

Volltextzugriff (PDF)

Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines

Journal of the National Comprehensive Cancer Network, 2014-11, Vol.12 (11), p.1517

2014

Volltextzugriff (PDF)

Primary Leiomyosarcoma of the Calvarium with Intracranial Extension: a Case Report

Indian journal of surgical oncology, 2020-09, Vol.11 (Suppl 2), p.165-169

2020

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(148)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(188)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma

Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study

Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma

Bevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma

Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models

The Presence of Survivin on B Cells from Myasthenia Gravis Patients and the Potential of an Antibody to a Modified Survivin Peptide to Alleviate Weakness in an Animal Model

Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth In Vivo

Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination

Black Bone Disease of the Skull

Disparities among racial/ethnic groups of patients diagnosed with ependymoma: analyses from the Surveillance, Epidemiology and End Results (SEER) registry

Lateral Temporal Approach for Image-Guided Stereotactic Biopsy of Pineal Region Tumors

Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade glioma

Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma

Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells

Life-Threatening Mannitol-Induced Hyperkalemia in Neurosurgical Patients

Site-Specific Conjugation of Boron-Containing Dendrimers to Anti-EGF Receptor Monoclonal Antibody Cetuximab (IMC-C225) and Its Evaluation as a Potential Delivery Agent for Neutron Capture Therapy

Meta-analysis of overall survival and postoperative neurologic deficits after resection or biopsy of butterfly glioblastoma

KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma

Novel vaccines for glioblastoma: clinical update and perspective

Molecular Targeting and Treatment of Composite EGFR and EGFRvIII-Positive Gliomas Using Boronated Monoclonal Antibodies

Molecular Targeting and Treatment of an Epidermal Growth Factor Receptor–Positive Glioma Using Boronated Cetuximab

Radiologic response to radiation therapy concurrent with temozolomide for progressive simple dysembryoplastic neuroepithelial tumor

Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines

Primary Leiomyosarcoma of the Calvarium with Intracranial Extension: a Case Report

Suchergebnisse filtern